HISTIOCYTE SOCIETY (EIN 223098990) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1985

Legal Domicile

Principal Officer

KIM NICHOLS

Phone

8565896606

Tax Period

2023-01-01 to 2023-12-31

HISTIOCYTE SOCIETY, founded in 1985, is a small nonprofit in the Arts, Culture & Humanities sector that reported $214K in total revenue in fiscal year 2023. Revenue grew 16% year-over-year, indicating healthy expansion. The organization ran a surplus of $53K, a strong 25% operating margin.

Mission

TO ADVANCE KNOWLEDGE ABOUT AND IMPROVE OUTCOMES FOR PATIENTS WITH HISTIOCYTIC DISORDERS THROUGH CLINICAL AND BASIC RESEARCH AND EDUCATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $41,048

Program Service Revenue $171,499

Investment Income $1,202

Other Revenue $0

TOTAL REVENUE $213,749

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $159,994

Other Expenses $160,745

TOTAL EXPENSES $160,745

Year-over-Year Comparison

	2023	2022	Change
Revenue	$213,749	$184,558	+0.2%
Expenses	$160,745	$172,201	-0.1%
Net Income	$53,004	$12,357	+3.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ASTRID VAN HALTEREN	MEMBER AT LARGE	1.00	Officer Director	$0	$0	$0
KARIN BEUTEL	SECRETARY	1.00	Officer Director	$0	$0	$0
KIM NICHOLS	PRESIDENT	1.00	Officer Director	$0	$0	$0
JENNIFER PICARSIC	TREASURER	1.00	Officer Director	$0	$0	$0
OUSSAMA ABLA	MEMBER AT LARGE	1.00	Director	$0	$0	$0
VASANTA NANDURI	PRESIDENT-ELECT	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$213,749	$160,745	$263,728	$53,004
2022	$184,558	$172,201	$214,717	$12,357
2021	$59,950	$20,440	$198,974	$39,510
2020	$41,700	$79,556	$160,294	$-37,856
2019	$236,210	$169,475	$231,095	$66,735
2018	$212,500	$222,408	$146,285	$-9,908

HISTIOCYTE SOCIETY